Jobs / United States / Iovance Biotherapeutics INC

Iovance Biotherapeutics INC

Associate Director, Cell Therapy Non-Personal Promotions

Remote · Remote · region not stated Posted today

Apply on company site ↗ Source: Company careers site Tailor my CV

Free account: one tailored CV and cover letter included. You always apply on the employer’s own page.

Sponsorship verdict

Sponsorship possible

One solid signal, not two. Worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordThe US Department of Labor certified 1 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Apr 2026) — the step every H-1B hire needs first.
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
  • What Iovance Biotherapeutics INC paid sponsored hires in similar roles1 certified filing for “Director, IT Infrastructure and Operations” (Software Developers) in CA: $258k–$258k, median $258k.
  • Confirmed live todayWhen a source last listed this job as open.
Details and sources
Employer is on a government sponsor record
The US Department of Labor certified 1 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Apr 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
No salary bar for this route
H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
What Iovance Biotherapeutics INC paid sponsored hires in similar roles
1 certified filing for “Director, IT Infrastructure and Operations” (Software Developers) in CA: $258k–$258k, median $258k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.

About the role

About   Iovance Biotherapeutics, Inc.   Iovance Biotherapeutics , Inc.  is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time treatment for previously treated advanced melanoma, now approved in three global markets and available at more than 95 authorized treatment centers. The  Iovance TIL platform  spans registrational trials and next-generation programs in additional solid tumors, including gene-edited and IL-12 tethered TIL therapies, next-generation IL-2, and precision immuno-oncology approaches. As the first and only company to take TIL therapy from concept to a broadly accessible commercial treatment, Iovance operates as an end-to-end cell therapy company, anchored by fully owned, centralized U.S.-based manufacturing that is scaled to serve thousands of cancer patients worldwide each year. For more information, please visit  www.iovance.com . Amtagvi® and its accompanying design marks, Proleukin ® , Iovance ® , and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or ts subsidiaries. All other trademarks and registered trademarks are the property of their respective owners. Information on Iovance’s broad, industry-leading patent portfolio is available on the Intellectual Property page on  www.iovance.com . Overview The Associate Director, Cell Therapy Non-Personal Promotions will oversee the management and execution of non-personal promotion (NPP) content for both HCP and patient audiences, ensuring cohesive, high-impact engagement across digital channels. This role also offers the opportunity to build and scale best-in-class digital engagement models in close partnership with Brand HCP and Patient business leads, Insights, and agency teams. Specific Responsibilities • Support non-personal promotion (NPP) omnichannel execution while identifying and designing integrated engagement opportunities aligned to customer insights, audience segmentation, and brand objectives. • Partner with both HCP and Patient Marketing business leads to understand engagement strategy, objectives, market research, and key priorities. • Lead HCP NPP planning and execution to support education, engagement, and message reinforcement across relevant digital and media channels. • Lead patient and caregiver NPP planning and execution to support disease-state education, branded engagement, and appropriate journey-based communications. • Translate brand objectives, customer insights, audience segmentation, and market research into engaging and effective non-personal promotional campaigns that meet audience needs and preferences while ensuring consistent messaging across multiple digital channels. • Partner with and manage day-to-day activities with the media agency. • Partner with business leads and BAI to analyze NPP campaign performance, define and track KPIs, develop dashboards, identify actionable insights, and optimize future initiatives through ongoing test-and-learn planning. • Offer targeted digital solutions and strategies to enhance NPP, brand, and disease-state education strategies and reach the right HCPs, patients, and caregivers. • Identify and evaluate new marketing technology platforms that support future readiness and engagement models such as AI and emerging digital solutions. • Serve as the NPP content owner in the promotional review committee process, partnering with the weekly review team to manage assets from creation through execution across NPP channels. • Collaborate closely with cross-functional stakeholders (Medical Affairs, Market Access, Commercial, Legal) to ensure alignment of NPP brand strategy and execution is effective a

Apply on company site ↗